New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca's Covid-19 jab.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tdZK2r
via IFTTT
0 comments:
Post a Comment